EUVIMEDEUVIMED entdecken
Crossref

Bone Health Care Pathway for Non-metastatic Prostate Cancer Patients on Radiation and Androgen Deprivation Therapy

Isabella Palumbo, Carmelinda Ruggiero, Eleonora Festa, Michelantonio DE Fano, Marta Baroni, Rita Bellavita, Gianluca Ingrosso, Simonetta Saldi, Michele Duranti, Patrizia Mecocci, Alberto Falorni, Cynthia Aristei

Anticancer Research · 2023-01 · 43 (1) · 493-499

DOI: 10.21873/anticanres.16186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 30.12.2022. Verfasst von Isabella Palumbo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Oncology Section, University of Perugia and Perugia General Hospital, Perugia, Italy; isabella.palumbo@unipg.it. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Bone Diseases, Metabolic, Fractures, Bone. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Survival rates of prostate cancer (PCa) patients have improved considerably as a result of earlier diagnosis and therapies, including radiotherapy (RT) and androgen deprivation therapy (ADT). Patients on ADT develop cancer treatment-induced bone loss (CTIBL) and a high risk of fragility fractures. Bone health (BH) assessment is strongly recommended, together with timely initiation of treatments, to counteract CTIBL and preserve bone strength. Therefore, we decided to develop an interdisciplinary pathway of care (IPC) dedicated to non-metastatic PCa patients on long-term ADT and RT. PATIENTS AND METHODS: An interdisciplinary team allocated resources to support an IPC to manage patients' CTIBL and prevent fragility fractures. The team provided a diagnostic and therapeutic workflow according to patients' and professional perspectives, consistent with recommendations and healthcare policies. The hospital's quality department certified the IPC, the Ethical Committee approved procedures over the workflow. The Fracture Liaison Service (FLS) standards inspired services and professionals' activities and interactions. RESULTS: Preliminary data support the feasibility of the IPC from professionals' and patients' perspectives. Median age of the enrolled patients was 75 years, more than a half (58.9%) had low grade osteopenia or normal BMD (T-score ≥-1.5 standard deviation, SD), while 23.5% and 17.6% had osteoporosis and osteopenia, respectively. The IPC meets the requirements of a FLS concerning crucial indicators. CONCLUSION: Our IPC was a suitable approach to assure timely identification, assessment, initiation, and monitoring of adherence to anti-fracture treatments among non-metastatic PCa patients on long-term ADT and RT. Further data are required to show its effectiveness on fragility fracture prevention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsBone Diseases, MetabolicFractures, BoneMaleHumansAgedAndrogen AntagonistsBone DensityAndrogensCritical Pathways

Stichwörter der Autor:innen

Non-metastatic prostate cancerandrogen deprivation therapycancer treatment-induced bone lossradiotherapy

Substanzen

Androgen AntagonistsAndrogens

Autor:innen und Institutionen

  • Radiation Oncology Section, University of Perugia and Perugia General Hospital, Perugia, Italy; isabella.palumbo@unipg.it.
  • Geriatric Unit, University of Perugia and Perugia General Hospital, Perugia, Italy.
  • Radiation Oncology Section, University of Perugia, Perugia, Italy.
  • Internal Medicine and Endocrinological and Metabolic Sciences Section, University of Perugia and Perugia General Hospital, Perugia, Italy.
  • Radiation Oncology Division, Perugia General Hospital, Perugia, Italy.
  • Radiation Oncology Section, University of Perugia and Perugia General Hospital, Perugia, Italy.

Zitieren

APA

Palumbo, I., Ruggiero, C., Festa, E., DE Fano, M., Baroni, M., Bellavita, R., Ingrosso, G., Saldi, S., Duranti, M., Mecocci, P., Falorni, A., & Aristei, C. (2023). Bone Health Care Pathway for Non-metastatic Prostate Cancer Patients on Radiation and Androgen Deprivation Therapy. Anticancer Research, 43(1), 493-499. https://doi.org/10.21873/anticanres.16186

Vancouver

Palumbo I, Ruggiero C, Festa E, DE Fano M, Baroni M, Bellavita R, et al. Bone Health Care Pathway for Non-metastatic Prostate Cancer Patients on Radiation and Androgen Deprivation Therapy. Anticancer Research. 2023;43(1):493-499. doi:10.21873/anticanres.16186

BibTeX
@article{Palumbo2023,
  author = {Palumbo, Isabella and Ruggiero, Carmelinda and Festa, Eleonora and DE Fano, Michelantonio and Baroni, Marta and Bellavita, Rita and Ingrosso, Gianluca and Saldi, Simonetta and Duranti, Michele and Mecocci, Patrizia and Falorni, Alberto and Aristei, Cynthia},
  title = {Bone Health Care Pathway for Non-metastatic Prostate Cancer Patients on Radiation and Androgen Deprivation Therapy},
  journal = {Anticancer Research},
  year = {2023},
  volume = {43},
  number = {1},
  pages = {493--499},
  doi = {10.21873/anticanres.16186}
}
Kostenlos starten →